BMY vs FBK · P/E 17, rev $24.46B vs P/E 17, rev $454.8M
Bristol-Myers Squibb Company (BMY) versus FB Financial Corp (FBK) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
FB Financial Corp (FBK) is a banks - regional company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported FBK revenue for 2026-06-30 was $454.8M. Net income was $116.2M. FBK currently screens at market cap $2.57B and trailing P/E 17.4.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. FBK currently screens at market cap $2.57B and trailing P/E 17.4.
Not investment advice. Open the BMY and FBK stock pages for the full models.
Not investment advice.